Protagonist Therapeutics, Inc. - PTGX

SEC FilingsOur PTGX Tweets

About Gravity Analytica

Recent News

  • 03.28.2026 - BioSpace covers ICOTYDE™ FDA Approval
  • 03.28.2026 - U.S. FDA Approves ICOTYDE™ (icotrokinra)
  • 03.12.2026 - Barclays Global Healthcare Conference
  • 02.25.2026 - Barclays 28th Annual Global Healthcare Conference
  • 02.25.2026 - Citizens Life Sciences Conference
  • 02.24.2026 - Jefferies Biotech on the Beach Summit
  • 02.24.2026 - Leerink Global Healthcare Conference

Recent Filings

  • 03.27.2026 - 4 Statement of changes in beneficial ownership of securities
  • 03.27.2026 - 4 Statement of changes in beneficial ownership of securities
  • 03.27.2026 - 4 Statement of changes in beneficial ownership of securities
  • 03.27.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 03.26.2026 - 144 Report of proposed sale of securities
  • 03.26.2026 - 144 Report of proposed sale of securities
  • 03.26.2026 - 144 Report of proposed sale of securities
  • 03.25.2026 - 4 Statement of changes in beneficial ownership of securities
  • 03.24.2026 - 144 Report of proposed sale of securities
  • 02.25.2026 - EX-99.1 EX-99.1